Kebang Hu
Lequn Branch
Changchun, 130031, China
Changchun, 130031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer.
Journal: International journal of nanomedicine
Published: March 14, 2024
Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy.
Journal: Frontiers in immunology
Published: July 23, 2023
TiO2 nanoparticles promote tumor metastasis by eliciting pro-metastatic extracellular vesicles.
Journal: Journal of nanobiotechnology
Published: July 21, 2023
Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on the current status and perspectives.
Journal: Frontiers in oncology
Published: March 19, 2023
Current progress of nanomedicine for prostate cancer diagnosis and treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 31, 2022
Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases.
Journal: Nanoscale
Published: May 11, 2021
Identification of Core Genes and Potential Drugs for Castration-Resistant Prostate Cancer Based on Bioinformatics Analysis.
Journal: DNA and cell biology
Published: February 27, 2020
Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation.
Journal: Saudi journal of biological sciences
Published: March 27, 2018
miR-106a contributes to prostate carcinoma progression through PTEN.
Journal: Oncology letters
Published: February 01, 2017
Last Updated: 09/26/2026